title: Implications of ejection fraction value for trastuzumab.
authors.forename: D
authors.initials: D
authors.lastname: Schlosshan
authors.forename: C
authors.initials: C
authors.lastname: Dickinson
authors.forename: R
authors.initials: R
authors.lastname: Sapsford
authors.forename: D
authors.initials: D
authors.lastname: Dodwell
authors.forename: T
authors.initials: T
authors.lastname: Perren
mesh_terms: D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000494:pharmacology*; D006801:Humans; D013318:Stroke Volume / Q000187:drug effects*; D000068878:Trastuzumab
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068878:Trastuzumab